Non-cytochrome P450-mediated bioactivation and its toxicological relevance

References

• Adams JD, Sayer JM, Chadha A, et al. (1999). The proximate carcinogen trans-3,4-dihydroxy-3,4-dihydro-dibenz[c,h]acridine is oxidized stereoselectively and regioselectively by cytochrome 1A1, epoxide hydrolase and hepatic microsomes from 3-methylcholanthrene-treated rats. Chem Biol Interact 122:117–135.
   PubMed Web of Science ®Google Scholar
• Amin S, Desai D, Hecht SS. (1993). Tumor-initiating activity on mouse skin of bay region diol-epoxides of 5,6-dimethylchrysene and benzo[c]phenanthrene. Carcinogenesis 14:2033–2037.
   PubMed Web of Science ®Google Scholar
• Amin S, Misra B, Braley J, Hecht SS. (1991). Comparative tumorigenicity in newborn mice of chrysene- and 5-alkylchrysene-1,2-diol-3,4-epoxides. Cancer Lett 58:115–118.
   PubMed Web of Science ®Google Scholar
• Baer BR, DeLisle RK, Allen A. (2009). Benzylic oxidation of gemfibrozil-1-O-beta-glucuronide by P450 2C8 leads to heme alkylation and irreversible inhibition. Chem Res Toxicol 22:1298–1309.
   PubMed Web of Science ®Google Scholar
• Bailey MJ, Dickinson RG. (2003). Acyl glucuronide reactivity in perspective: Biological consequences. Chem Biol Interact 145:117–137.
   PubMed Web of Science ®Google Scholar
• Baillie TA. (2008). Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem Res Toxicol 21:129–137.
   PubMed Web of Science ®Google Scholar
• Baillie TA, Slatter JG. (1991). Glutathione: A vehicle for the transport of chemically reactive metabolites in vivo. Acc Chem Res 24:264–270.
   Web of Science ®Google Scholar
• Barr JT, Choughule K, Jones JP. (2014). Enzyme kinetics, inhibition, and regioselectivity of aldehyde oxidase. Methods Mol Biol 1113:167–186.
   PubMedGoogle Scholar
• Bell CC, Santoyo Castelazo A, Yang EL, et al. (2013). Oxidative bioactivation of abacavir in subcellular fractions of human antigen presenting cells. Chem Res Toxicol 26:1064–1072.
   PubMed Web of Science ®Google Scholar
• Barski OA, Tipparaju SM, Bhatnagar A. (2008). The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab Rev 40:553–624.
   PubMed Web of Science ®Google Scholar
• Begleiter AK, Leith M. (1995). Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro. Biochem Pharmacol 50:1281–1286.
   PubMed Web of Science ®Google Scholar
• Belinsky M, Jaiswal AK. (1993). NAD(P)H: Quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 12:103–117.
   PubMed Web of Science ®Google Scholar
• Boatman RJ, English JC, Perry LG, Fiorica LA. (2000). Covalent protein adducts of hydroquinone in tissues from rats: Quantitation of sulfhydryl-bound forms following single gavage or intraperitoneal administration or repetitive gavage administration. Chem Res Toxicol 13:861–872.
   PubMed Web of Science ®Google Scholar
• Boelsterli UA. (2002). Xenobiotic acyl glucuronides and acyl CoA thioesters as protein-reactive metabolites with the potential to cause idiosyncratic drug reactions. Cur Drug Metabolism 3:439–450.
   PubMedGoogle Scholar
• Boelsterli UA, Redinbo MR, Saitta KS. (2013). Multiple NSAID-induced hits injure the small intestine: Underlying mechanisms and novel strategies. Toxicol Sci 131:654–667.
   PubMed Web of Science ®Google Scholar
• Bouman HJ, Schömig E, van Werkum JW, et al. (2011). Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nat Med 17:110–116.
   PubMed Web of Science ®Google Scholar
• Boyd JA, Eling TE. (1981). Prostaglandin endoperoxide synthetase-dependent cooxidation of acetaminophen to intermediates which covalently bind in vitro to rabbit renal medullary microsomes. J Pharmacol Exp Ther 219:659–664.
   PubMed Web of Science ®Google Scholar
• Boyda HN, Procyshyn RM, Pang CCY, et al. (2013). Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: A comparison with olanzapine. PLoS One 8:1–11.
   Web of Science ®Google Scholar
• Brunmark A, Cadenas E, Lind C, et al. (1987). DT-diaphorase-catalyzed two electron reduction of quinone epoxides. Free Radic Biol Med 3:181–188.
   PubMed Web of Science ®Google Scholar
• Bylund J, Macsari I, Besidski Y, et al. (2012). Novel bioactivation mechanism of reactive metabolite formation from phenyl methyl-isoxazoles. Drug Metab Dispos 40:2185–2191.
   PubMed Web of Science ®Google Scholar
• Cai TT, Yao L, Turesky RJ. (2016). Bioactivation of heterocyclic aromatic amines by UDP glucuronosyltransferases. Chem Res Toxicol 29:879–891.
   PubMed Web of Science ®Google Scholar
• Carter PJ, Senter PD. (2013). Antibody-drug conjugates for cancer therapy. Cancer J 14:154–169.
   Web of Science ®Google Scholar
• Cashman JR, Hanzlik RP. (1981). Microsomal oxidation of thiobenzamide. A photometric assay for the flavin-containing monooxygenase. Biochem Biophys Res Commun 98:147–153.
   PubMed Web of Science ®Google Scholar
• Cashman JR, Proudfoot J, Pate DW, Hogberg T. (1988). Stereoselective N-oxygenation of zimeldine and homozimeldine by the flavin-containing monooxygenase. Drug Metab Dispos 16:616–622.
   PubMed Web of Science ®Google Scholar
• Cashman JR, Xiong YN, Xu L, Janowsky A. (1999). N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): Role in bioactivation and detoxication. J Pharmacol Exp Ther 288:1251–1260.
   PubMed Web of Science ®Google Scholar
• Cashman JR, Yang ZC, Hogberg T. (1990). Oxidation of N-hydroxynorzimeldine to a stable nitrone by hepatic monooxygenases. Chem Res Toxicol 3:428–432.
   PubMed Web of Science ®Google Scholar
• Cerny MA. (2016). Prevalence of non-cytochrome P450-mediated metabolism in FDA approved oral and intravenous drugs: 2006–2015. Drug Metab Dispos 44:1246–1252.
   PubMed Web of Science ®Google Scholar
• Chari RVJ, Miller ML, Widdison WC. (2014). Antibody-drug conjugates: An emerging concept in cancer therapy. Angew Chem Int Ed Engl 53:3796–3827.
   PubMed Web of Science ®Google Scholar
• Charlton B, Redberg R. (2014). The trouble with dabigatran. BMJ 349:g4681–g4681.
   PubMed Web of Science ®Google Scholar
• Charneira C, Godinho AL, Oliveira MC, et al. (2011). Reactive aldehyde metabolites from the anti-HIV drug abacavir: Amino acid adducts as possible factors in abacavir toxicity. Chem Res Toxicol 24:2129–2141.
   PubMed Web of Science ®Google Scholar
• Chen G, Yin S, Maiti S, Shao X. (2002). 4-Hydroxytamoxifen sulfation metabolism. J Biochem Mol Toxicol 16:279–285.
   PubMed Web of Science ®Google Scholar
• Chen J, Mannargudi BM, Xu L, Uetrecht J. (2008). Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash. Chem Res Toxicol 21:1862–1870.
   PubMed Web of Science ®Google Scholar
• Chiba K, Trevor A, Castagnoli N Jr. (1984). Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120:574–578.
   PubMed Web of Science ®Google Scholar
• Clement B, Lopian K. (2003). Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug. Drug Metab Dispos 31:645–651.
   PubMed Web of Science ®Google Scholar
• Collins MA, Neafsey EJ, Matsubara K, et al. (1992). Indole-N-methylation of beta-carbolines: The brain's bioactivation route to toxins in Parkinson's disease? Ann NY Acad Sci 648:263–265.
   PubMed Web of Science ®Google Scholar
• Corley RA, English JC, Hill TS, et al. (2000). Development of a physiologically based pharmacokinetic model for hydroquinone. Toxicol Appl Pharmacol 165:163–174.
   PubMed Web of Science ®Google Scholar
• Cooper AJL. (1998). Mechanisms of cysteine S-conjugate beta-lyases. Adv Enzymol 72:199–215.
   PubMedGoogle Scholar
• Curthoys NP, Hughey RP. (1979). Characterization and physiological function of rat renal gamma-glutamyltranspeptidase. Enzyme 24:383–403.
   PubMedGoogle Scholar
• Dahlin DC, Miwa GT, Lu AY, Nelson SD. (1984). N-acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc Nat Acad Sci USA 81:1327–1331.
   PubMed Web of Science ®Google Scholar
• Dansette PM, Levent D, Hessani A, Mansuy D. (2015). Bioactivation of clopidogrel and prasugrel: Factors determining the stereochemistry of the thiol metabolite double bond. Chem Res Toxicol 28:1338–1345.
   PubMed Web of Science ®Google Scholar
• Darnell M, Breitholtz K, Isin EM, et al. (2015). Significantly different covalent binding of oxidative metabolites, acyl glucuronides, and S-acyl CoA conjugates formed from xenobiotic carboxylic acids in human liver microsomes. Chem Res Toxicol 28:886–896.
   PubMed Web of Science ®Google Scholar
• Darnell M, Weidolf L. (2013). Metabolism of xenobiotic carboxylic acids: Focus on coenzyme A conjugation, reactivity, and interference with lipid metabolism. Chem Res Toxicol 26:1139–1155.
   PubMed Web of Science ®Google Scholar
• Davies AM, Martin EA, Jones RM, et al. (1995). Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts. Carcinogenesis 16:539–545.
   PubMed Web of Science ®Google Scholar
• Desmet VJ, Krstulovic B, Van Damme B. (1968). Histochemical study of rat liver in alpha-naphthyl isothiocyanate (ANIT) induced cholestasis. Am J Pathol 52:401–421.
   PubMed Web of Science ®Google Scholar
• Diamond S, Boer J, Maduskuie TP, Jr., et al. (2010). Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications. Drug Metab Dispos 38:1277–1285.
   PubMed Web of Science ®Google Scholar
• Dekant W. (2001). Chemical-induced nephrotoxicity mediated by glutathione S-conjugate formation. Toxicol Lett 124:21–36.
   PubMed Web of Science ®Google Scholar
• Dieckhaus CM, Santos WL, Sofia RD, Macdonald TL. (2001). The chemistry, toxicology, and identification in rat and human urine of 4-hydroxy-5-phenyl-1,3-oxazaperhydroin-2-one: A reactive metabolite in felbamate bioactivation. Chem Res Toxicol 14:958–964.
   PubMed Web of Science ®Google Scholar
• Dieckhaus CM, Thompson CD, Roller SG, Macdonald TL. (2002). Mechanisms of idiosyncratic drug reactions: The case of felbamate. Chem Biol Interact 142:99–117.
   PubMed Web of Science ®Google Scholar
• Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP. (2001). Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology 167:73–81.
   PubMed Web of Science ®Google Scholar
• Ding A, Ojingwa JC, McDonagh AF, et al. (1993). Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc Natl Acad Sci USA 90:3797–3801.
   PubMed Web of Science ®Google Scholar
• Doronina SO, Toki BE, Torgov MY, et al. (2003). Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat Biotechnol 21:778–784.
   PubMed Web of Science ®Google Scholar
• Duncan R, Kopecek J, Rejmanova P, et al. (1983). Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. Biochim Biophys Acta 755:518–521.
   PubMed Web of Science ®Google Scholar
• Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. (2004). Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 17:3–16.
   PubMed Web of Science ®Google Scholar
• Dowers TS, Qin ZH, Thatcher GR, Bolton JL. (2006). Bioactivation of selective estrogen receptor modulators (SERMs). Chem Res Toxicol 19:1125–1137.
   PubMed Web of Science ®Google Scholar
• Falany CN, Wheeler J, Coward L, et al. (1992). Bioactivation of 7-hydroxymethyl-12-methylbenz[a]anthracene by rat liver bile acid sulfotransferase I. J Biochem Toxicol 7:241–248.
   PubMedGoogle Scholar
• Fan PW, Bolton JL. (2001). Bioactivation of tamoxifen to metabolite E quinone methide: Reaction with glutathione and DNA. Drug Metab Dispos 29:891–896.
   PubMed Web of Science ®Google Scholar
• Fields JZ, Albores R, Neafsey EJ, Collins MA. (1992). Similar inhibition of mitochondrial respiration by 1-methyl-4-phenyl-pyridinium (MPP+) and by a unique N-methylated beta-carboline analog, 2,9-dimethyl-norharman (2,9Me2NH). Ann NY Acad Sci 648:272–274.
   PubMed Web of Science ®Google Scholar
• Fourie J, Guziec F, Guziec L, et al. (2004). Structure-activity study with bioreductive benzoquinone alkylating agents: Effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity. Cancer Chemother Pharmacol 53:191–203.
   PubMed Web of Science ®Google Scholar
• Fröhlich K, Girreser U, Clement B. (2005). Metabolism of benzamidoxime (N-hydroxyamidine) in human hepatocytes and role of UDP-glucuronosyltransferases. Xenobiotica 35:17–25.
   PubMed Web of Science ®Google Scholar
• Funk C, Pantze M, Jehle L, et al. (2001a). Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology 167:83–98.
   PubMed Web of Science ®Google Scholar
• Funk C, Ponelle C, Scheuermann G, Pantze M. (2001b). Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59:627–635.
   PubMed Web of Science ®Google Scholar
• Gamboa da Costa G, Pereira PC, Churchwell MI, et al. (2007). DNA adduct formation in the livers of female Sprague–Dawley rats treated with toremifene or alpha-hydroxytoremifene. Chem Res Toxicol 20:300–310.
   PubMed Web of Science ®Google Scholar
• Gan J, Qu Q, He B, et al. (2008). Troglitazone thiol adduct formation in human liver microsomes: Enzyme kinetics and reaction phenotyping. Drug Metab Lett 2:184–189.
   PubMedGoogle Scholar
• Garattini E, Terao M. (2013). Aldehyde oxidase and its importance in novel drug discovery: Present and future challenges. Expert Opin Drug Discov 8:641–654.
   PubMed Web of Science ®Google Scholar
• Gearhart DA, Collins MA, Lee JM, Neafsey EJ. (2000). Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol Dis 7:201–211.
   PubMed Web of Science ®Google Scholar
• Gearhart DA, Neafsey EJ, Collins MA. (1997). Characterization of brain beta-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease. Neurochem Res 22:113–121.
   PubMed Web of Science ®Google Scholar
• Ghaoui R, Sallustio BC, Burcham PC, Fontaine FR. (2003). UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytes. Chem Biol Interact 145:201–211.
   PubMed Web of Science ®Google Scholar
• Glatt H. (1997). Sulfation and sulfotransferases 4: Bioactivation of mutagens via sulfation. FASEB J 11:314–321.
   PubMed Web of Science ®Google Scholar
• Glatt H. (2000). Sulfotransferases in the bioactivation of xenobiotics. Chem Biol Interact 129:141–170.
   PubMed Web of Science ®Google Scholar
• Glatt H, Engelke CE, Pabel U, et al. (2000). Sulfotransferases: Genetics and role in toxicology. Toxicol Lett 112–113:341–348.
   PubMed Web of Science ®Google Scholar
• Grillo MP. (2011). Drug-S-acyl-glutathione thioesters: Synthesis, bioanalytical properties, chemical reactivity, biological formation and degradation. Curr Drug Metab 12:229–244.
   PubMed Web of Science ®Google Scholar
• Grillo MP, Chiellini G, Tonelli M, Benet LZ. (2001). Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats. Drug Metab Dispos 29:1210–1215.
   PubMed Web of Science ®Google Scholar
• Grilo NM, Antunes AM, Caixas U, et al. (2013). Monitoring abacavir bioactivation in humans: Screening for an aldehyde metabolite. Toxicol Lett 219:59–64.
   PubMed Web of Science ®Google Scholar
• Grilo NM, Charneira C, Pereira SA, et al. (2014). Bioactivation to an aldehyde metabolite–possible role in the onset of toxicity induced by the anti-HIV drug abacavir. Toxicol Lett 224:416–423.
   PubMed Web of Science ®Google Scholar
• Grollman AP. (2013). Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease. Environ Mol Mutagen 54:1–7.
   PubMed Web of Science ®Google Scholar
• Guengerich F. (2005). Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8:E101–E111.
   Web of Science ®Google Scholar
• Gutierrez PL. (2000). The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: A review. Free Radic Biol Med 29:263–275.
   PubMed Web of Science ®Google Scholar
• He K, Talaat RE, Pool WF, et al. (2004). Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved. Drug Metab Dispos 32:639–646.
   PubMed Web of Science ®Google Scholar
• Hahn R, Wendel A, Flohé L. (1978). The fate of extracellular glutathione in the rat. Biochim Biophys Acta 539:324–337.
   PubMed Web of Science ®Google Scholar
• Hanigan MH, Gallagher BC, Taylor PT, Large MK. (1994). Inhibition of gama-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 54:5925–5929.
   PubMed Web of Science ®Google Scholar
• Hanigan MH, Lykissa ED, Townsend DM, et al. (2001). Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am J Pathol 159:1889–1894.
   PubMed Web of Science ®Google Scholar
• Havemeyer A, Bittner F, Wollers S, et al. (2006). Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme. J Biol Chem 281:34796–34802.
   PubMed Web of Science ®Google Scholar
• Hein DW. (2006). N-acetyltransferase 2 genetic polymorphism: Effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25:1649–1658.
   PubMed Web of Science ®Google Scholar
• Henderson MC, Krueger SK, Stevens JF, Williams DE. (2004). Human flavin-containing monooxygenase form 2 S-oxygenation: Sulfenic acid formation from thioureas and oxidation of glutathione. Chem Res Toxicol 17:633–640.
   PubMed Web of Science ®Google Scholar
• Hinton LK, Galetin A, Houston JB. (2008). Multiple inhibition mechanisms and prediction of drug-drug interactions: Status of metabolism and transporter models as exemplified by gemfibrozil-drug interactions. Pharm Res 25:1063–1074.
   PubMed Web of Science ®Google Scholar
• Horng H, Benet LZ. (2013). Characterization of the acyl-adenylate linked metabolite of mefenamic Acid. Chem Res Toxicol 26:465–476.
   PubMed Web of Science ®Google Scholar
• Howell BA, Siler SQ, Watkins PB. (2014). Use of a systems model of drug-induced liver injury (DILIsym((R))) to elucidate the mechanistic differences between acetaminophen and its less-toxic isomer, AMAP, in mice. Toxicol Lett 226:163–172.
   PubMed Web of Science ®Google Scholar
• Ikehata K, Duzhak TG, Galeva NA, et al. (2008). Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo. Chem Res Toxicol 21:1432–1442.
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Obach RS, Dalvie D, Zientek MA. (2013). Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Expert Opin Drug Metab Toxicol 9:168.
   Web of Science ®Google Scholar
• Ioannides C, Lewis DFV. (2004). Cytochromes P450 in the bioactivation of chemicals. Curr Top Med Chem 4:1767–1788.
   PubMed Web of Science ®Google Scholar
• Ji T, Ikehata K, Koen YM, et al. (2007). Covalent modification of microsomal lipids by thiobenzamide metabolites in vivo. Chem Res Toxicol 20:701–708.
   PubMed Web of Science ®Google Scholar
• Jinsmaa Y, Florang VR, Rees JN, et al. (2011). Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease. Chem-Biol Interact 192:118–121.
   PubMed Web of Science ®Google Scholar
• Ju C, Uetrecht JP. (1999). Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther 288:51–56.
   PubMed Web of Science ®Google Scholar
• Kadlubar FF, Miller JA, Miller EC. (1977). Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res 37:805–814.
   PubMed Web of Science ®Google Scholar
• Kadlubar FF, Unruh LE, Flammang TJ, et al. (1981). Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. Chem Biol Interact 33:129–147.
   PubMed Web of Science ®Google Scholar
• Kassahun K, Pearson PG, Tang W, et al. (2001). Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem Res Toxicol 14:62–70.
   PubMed Web of Science ®Google Scholar
• Kazmi F, Barbara JE, Yerino P, Parkinson A. (2015). A long-standing mystery solved: The formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement. Drug Metab Dispos 43:523–533.
   PubMed Web of Science ®Google Scholar
• Keisu M, Andersson TB. (2010). Drug-induced liver injury in humans: The case of ximelagatran. Handb Exp Pharmacol 196: 407–418.
   PubMedGoogle Scholar
• Kalgutkar AS, Dalvie D. (2015). Predicting toxicities of reactive metabolite–positive drug candidates. Annu Rev Pharmacol Toxicol 55:35–54.
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Gardner I, Obach RS, et al. (2005). A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:161–225.
   PubMed Web of Science ®Google Scholar
• Kapetanovic IM, Torchin CD, Thompson CD, et al. (1998). Potentially reactive cyclic carbamate metabolite of the antiepileptic drug felbamate produced by human liver tissue in vitro. Drug Metab Dispos 26:1089–1095.
   PubMed Web of Science ®Google Scholar
• Kawashima K, Hosoi K, Naruke T, et al. (1999). Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zeleplon, between monkeys and rats. Drug Metab Dispos 27:422–428.
   PubMed Web of Science ®Google Scholar
• Khan AA, Rahmani AH, Aldebasi YH, Aly SM. (2014). Biochemical and pathological studies on peroxidases -an updated review. Global J Health Sci 6:87–98.
   PubMedGoogle Scholar
• King CM, Land SJ, Jones RF, et al. (1997). Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat Res 376:123–128.
   PubMed Web of Science ®Google Scholar
• King CM. (1995). Tamoxifen and the induction of cancer. Carcinogenesis 16:1449–1454.
   PubMed Web of Science ®Google Scholar
• King RS, Teitel CH, Kadlubar FF. (2000). In vitro bioactivation of N-hydroxy-2-amino-alpha-carboline. Carcinogenesis 21:1347–1354.
   PubMed Web of Science ®Google Scholar
• Knights KM, Sykes MJ, Miners JO. (2007). Amino acid conjugation: Contribution to the metabolism and toxicity of xenobiotic carboxylic acids. Expert Opin Drug Metab Toxicol 3:159–168.
   PubMed Web of Science ®Google Scholar
• Kochansky CJ, Xia YQ, Wang S, et al. (2005). Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide. Drug Metab Dispos 33:1894–1904.
   PubMed Web of Science ®Google Scholar
• Krueger SK, Williams DE. (2005). Mammalian flavin-containing monooxygenases: Structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106:357–387.
   PubMed Web of Science ®Google Scholar
• Kubow S, Wells PG. (1989). In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase. Mol Pharmacol 35:504–511.
   PubMed Web of Science ®Google Scholar
• Koukouritaki SB, Simpson P, Yeung CK, et al. (2002). Human hepatic flavin-containing monooxygease I (FMO1) and 3 (FMO3) developmental expression. Pediatric Res 51:236–242.
   PubMed Web of Science ®Google Scholar
• Kumagai Y, Tsurutani Y, Shinyashiki M, et al. (1997). Bioactivation of lapachol responsible for DNA scission by NADPH-cytochrome P450 reductase. Environ Toxicol Pharmacol 3:245–250.
   PubMed Web of Science ®Google Scholar
• Kumar S, Chang RL, Wood AW, et al. (2001). Tumorigenicity of racemic and optically pure bay region diol epoxides and other derivatives of the nitrogen heterocycle dibenz[a,h]acridine on mouse skin. Carcinogenesis 22:951–955.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sikka HC, Dubey SK, et al. (1989). Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline. Cancer Res 49:20–24.
   PubMed Web of Science ®Google Scholar
• Kumar S, Samuel K, Subramanian R, et al. (2002). Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: Role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. J Pharmacol Exp Ther 303:969–978.
   PubMed Web of Science ®Google Scholar
• Lange RW, Day BW, Lemus R, et al. (1999). Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene. Chem Res Toxicol 12:931–936.
   PubMed Web of Science ®Google Scholar
• Lassila T, Hokkanen J, Aatsinki SM, et al. (2015). Toxicity of carboxylic acid-containing drugs: The role of acyl migration and CoA conjugation investigated. Chem Res Toxicol 28:2292–2303.
   PubMed Web of Science ®Google Scholar
• Leppik IE. (2004). Zonisamide: Chemistry, mechanism of action, and pharmacokinetics. Seizure 1:S5–S9.
   Web of Science ®Google Scholar
• Lewis JP, Fisch AS, Ryan K, et al. (2011). Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response. Clin Pharmacol Ther 90:568–574.
   PubMed Web of Science ®Google Scholar
• Li C, Grillo MP, Benet LZ. (2003). In vitro studies on the chemical reactivity of 2,4-dichlorophenoxyacetyl-S-acyl-CoA thioester. Toxicol Appl Pharmacol 187:101–109.
   PubMed Web of Science ®Google Scholar
• Li H, Cui H, Kundu TK, et al. (2008). Nitric oxide production from nitrite occurs primarily in tissues not in the blood: Critical role of xanthine oxidase and aldehyde oxidase. J Biol Chem 283:17855–17863.
   PubMed Web of Science ®Google Scholar
• Li Y, Xu J, Lai WG, et al. (2012). Metabolic switching of BILR 355 in the presence of ritonavir. II. Uncovering novel contributions by gut bacteria and aldehyde oxidase. Drug Etabol Dispos 40:1130–1137.
   PubMed Web of Science ®Google Scholar
• Liu L, Wells PG. (1995). Potential molecular targets mediating chemical teratogenesis: In vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant. Toxicol Appl Pharmacol 134:71–80.
   PubMed Web of Science ®Google Scholar
• Liu ZC, Uetrecht JP. (1995). Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells. J Pharmacol Exp Ther 275:1476–1483.
   PubMed Web of Science ®Google Scholar
• Lohr JW, Willsky GR, Acara MA. (1998). Renal drug metabolism. Pharmacol Rev 50:107–141.
   PubMed Web of Science ®Google Scholar
• Lobach AR, Uetrecht J. (2014). Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: Implications for drug-induced agranulocytosis. Chem Res Toxicol 27:699–709.
   PubMed Web of Science ®Google Scholar
• LoGuidice A, Wallace BD, Bendel L, et al. (2012). Pharmacologic targeting of bacterial beta-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J Pharmacol Exp Ther 341:447–454.
   PubMed Web of Science ®Google Scholar
• Longo DM, Yang Y, Watkins PB, et al. (2016). Elucidating differences in the hepatotoxic potential of tolcapone and entacapone with DILIsym((R)), a mechanistic model of drug-induced liver injury. CPT 5:31–39.
   Web of Science ®Google Scholar
• Lu W, Uetrecht JP. (2008). Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab Dispos 36:1624–1636.
   PubMed Web of Science ®Google Scholar
• Madden S, Maggs JL, Park BK. (1996). Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s). Drug Metab Dispos 24:469–479.
   PubMed Web of Science ®Google Scholar
• Maggs JL, Williams D, Pirmohamed M, Park BK. (1995). The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J Pharmacol Exp Ther 275:1463–1475.
   PubMed Web of Science ®Google Scholar
• Marques MM, Beland FA. (1997). Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide. Carcinogenesis 18:1949–1954.
   PubMed Web of Science ®Google Scholar
• Matsubara K, Collins MA, Akane A, et al. (1993). Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain. Brain Res 610:90–96.
   PubMed Web of Science ®Google Scholar
• Metushi I, Uetrecht J, Phillips E. (2016). Mechanism of isoniazid-induced hepatotoxicity: Then and now. Br J Clin Pharmacol 81:1030–1036.
   PubMed Web of Science ®Google Scholar
• Metushi IG, Nakagawa T, Uetrecht J. (2012). Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: Humans are more like mice than rats. Chem Res Toxicol 25:2567–2576.
   PubMed Web of Science ®Google Scholar
• Meyer DJ, Crease DJ, Ketterer B. (1995). Forward and reverse catalysis and product sequestration by human glutathione S-transferases in the reaction of GSH with dietary aralkyl isothiocyanates. Biochem J 306:565–569.
   PubMed Web of Science ®Google Scholar
• Mitchell JR, Zimmerman HJ, Ishak KG, et al. (1976). Isoniazid liver injury: Clinical spectrum, pathology, and probable pathogenesis. Ann Int Med 84:181–192.
   PubMed Web of Science ®Google Scholar
• Miho K, Yuji O, Katsunobu H, et al. (2015). Human intestinal Raf kinase inhibitor protein, RKIP, catalyzes prasugrel as a bioactivation hydrolase. Drug Metab Dispos 44:115–123.
   PubMed Web of Science ®Google Scholar
• Moghaddam MF, Grant DF, Cheek JM, et al. (1997). Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat Med 3:562–566.
   PubMed Web of Science ®Google Scholar
• Mohamed MM, Sloane BF. (2006). Cysteine cathepsins: Multifunctional enzymes in cancer. Nat Rev Cancer 6:764–775.
   PubMed Web of Science ®Google Scholar
• Moldeus P, Andersson B, Rahimtula A, Berggren M. (1982). Prostaglandin synthetase catalyzed activation of paracetamol. Biochem Pharmacol 31:1363–1368.
   PubMed Web of Science ®Google Scholar
• Morisseau C, Hammock BD. (2012). Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53:37–58.
   PubMed Web of Science ®Google Scholar
• Mutlib AE, Gerson RJ, Meunier PC, et al. (2000). The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats. Toxicol Appl Pharmacol 169:102–113.
   PubMed Web of Science ®Google Scholar
• Nelson E. (1965). Studies on the crystalluria potential of sulfamethoxydiazine. Chemotherapy 10:145–151.
   PubMed Web of Science ®Google Scholar
• Nelson SD, Dahlin DC, Rauckman EJ, Rosen GM. (1981). Peroxidase-mediated formation of reactive metabolites of acetaminophen. Mol Pharmacol 20:195–199.
   PubMed Web of Science ®Google Scholar
• Niemi M, Backman JT, Neuvonen M, Neuvonen PJ. (2003). Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: Potentially hazardous interaction between gemfibrozil and repaglinide. Diabetologia 46:347–351.
   PubMed Web of Science ®Google Scholar
• Nivinskas H, Staškevičiene S, Šarlauskas J, et al. (2002). Two-electron reduction of quinones by Enterobacter cloacae NAD(P)H:nitroreductase: Quantitative structure-activity relationships. Arch Biochem Biophys 403:249–258.
   PubMed Web of Science ®Google Scholar
• Novotna R, Wsol V, Xiong G, Maser E. (2008). Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto: Reductase (AKR) 1C3. Toxicol Lett 181:1–6.
   PubMed Web of Science ®Google Scholar
• O’Brien PJ. (1991). Molecular mechanisms of quinone cytotoxicity. Chen-Biol Interaction 80:1–41.
   PubMed Web of Science ®Google Scholar
• Oliveira RAS, Azevedo-Ximenes E, Luzzati R, Garcia RC. (2010). The hydroxy-naphthoquinone lapachol arrests mycobacterial growth and immunomodulates host macrophages. Int Immunopharmacol 10:1463–1473.
   PubMed Web of Science ®Google Scholar
• Ogilvie BW, Zhang D, Li W, et al. (2006). Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: Implications for drug-drug interactions. Drug Metab Dispos 34:191–197.
   PubMed Web of Science ®Google Scholar
• Okuda T, Norioka M, Shitara Y, Horie T. (2010). Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition. Toxicol Appl Pharmacol 248:242–248.
   PubMed Web of Science ®Google Scholar
• Olsen J, Li C, Bjornsdottir I, et al. (2005). In vitro and in vivo studies on acyl-coenzyme A-dependent bioactivation of zomepirac in rats. Chem Res Toxicol 18:1729–1736.
   PubMed Web of Science ®Google Scholar
• Olsen J, Li C, Skonberg C, et al. (2007). Studies on the metabolism of tolmetin to the chemically reactive acyl-coenzyme A thioester intermediate in rats. Drug Metab Dispos 35:758–764.
   PubMed Web of Science ®Google Scholar
• Orsler DJ, Ahmed-Choudhury J, Chipman JK, et al. (1999). ANIT-induced disruption of biliary function in rat hepatocyte couplets. Toxicol Sci 47:203–210.
   PubMed Web of Science ®Google Scholar
• Pare G, Eriksson N, Lehr T, et al. (2013). Genetic determinants of dabigatran plasma levels and their relation to bleeding. Circulation 127:1404–1412.
   PubMed Web of Science ®Google Scholar
• Park BK, Laverty H, Srivastava A, et al. (2011). Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem Biol Interact 192:30–36.
   PubMed Web of Science ®Google Scholar
• Pathak DN, Pongracz K, Bodell WJ. (1996). Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: Comparison with DNA adducts formed in the uterus of Sprague–Dawley rats treated with tamoxifen. Carcinogenesis 17:1785–1790.
   PubMed Web of Science ®Google Scholar
• Pellock JM. (1999). Felbamate in epilepsy therapy. Evaluating the risks. Drug Safety 21:225–239.
   PubMed Web of Science ®Google Scholar
• Pennell PB, Ogaily MS, Macdonald RL. (1995). Aplastic anemia in a patient receiving felbamate for complex partial seizures. Neurology 45:456–460.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Madden S, Park BK. (1996). Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism. Clin Pharmacokinet 31:215–230.
   PubMed Web of Science ®Google Scholar
• Potter DW, Miller DW, Hinson JA. (1986). Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione. Mol Pharmacol 29:155–162.
   PubMed Web of Science ®Google Scholar
• Preusch PC, Suttie JW. (1984). Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase. Arch Biochem Biophys 234:405–412.
   PubMed Web of Science ®Google Scholar
• Parman T, Chen G, Wells PG. (1998). Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis. J Biol Chem 273:25079–25088.
   PubMed Web of Science ®Google Scholar
• Pryde DC, Dalvie D, Hu Q, et al. (2010). Aldehyde oxidase: An enzyme of emerging importance in drug discovery. J Med Chem 53:8441–8460.
   PubMed Web of Science ®Google Scholar
• Rees JN, Florang VR, Eckert LL, Doorn JA. (2009). Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol. Chem Res Toxicol 22:1256–1263.
   PubMed Web of Science ®Google Scholar
• Regan SL, Maggs JL, Hammond TG, et al. (2010). Acyl glucuronides: The good, the bad and the ugly. Biopharm Drug Dispos 31:367–395.
   PubMed Web of Science ®Google Scholar
• Reny JL, Combescure C, Daali Y, et al. (2012). Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: A systematic review and meta-analysis. J Thromb Haemost 10:1242–1251.
   PubMed Web of Science ®Google Scholar
• Riley RJ, Kitteringham NR, Park BK. (1989). Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro. Br J Clin Pharmacol 28:482–487.
   PubMed Web of Science ®Google Scholar
• Ritter JK. (2000). Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem Biol Interact 129:171–193.
   PubMed Web of Science ®Google Scholar
• Rodriguez RJ, Acosta D Jr. (1997). N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Toxicology 117:123–131.
   PubMed Web of Science ®Google Scholar
• Rodriguez RJ, Proteau PJ, Marquez BL, et al. (1999). Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes. Drug Metab Dispos 27:880–886.
   PubMed Web of Science ®Google Scholar
• Sachse B, Meinl W, Sommer Y, et al. (2016). Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: A comparative study. Arch Toxicol 90:137–148.
   PubMed Web of Science ®Google Scholar
• Saunders LR, Bankovich AJ, Anderson WC, et al. (2015). A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci Transl Med 302:302ra136.
   Google Scholar
• Saha S, New LS, Ho HK, et al. (2010). Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes. Toxicol Lett 195:135–141.
   PubMed Web of Science ®Google Scholar
• Sallustio BC, Degraaf YC, Weekley JS, Burcham PC. (2006). Bioactivation of carboxylic acid compounds by UDP-Glucuronosyltransferases to DNA-damaging intermediates: Role of glycoxidation and oxidative stress in genotoxicity. Chem Res Toxicol 19:683–691.
   PubMed Web of Science ®Google Scholar
• Sanoh S, Tayama Y, Sugihara K, et al. (2015). Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Drug Metab Pharmacokinet 30:52–63.
   PubMed Web of Science ®Google Scholar
• Schulz H. (1987). Inhibitors of fatty acid oxidation. Life Sci 40:1443–1449.
   PubMed Web of Science ®Google Scholar
• Schmeiser HH, Stiborova M, Arlt VM. (2009). Chemical and molecular basis of the carcinogenicity of Aristolochia plants. Curr Opin Drug Discov Develop 12:141–148.
   PubMedGoogle Scholar
• Sharma AM, Novalen M, Tanino T, Uetrecht JP. (2013). 12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash. Chem Res Toxicol 26:817–827.
   PubMed Web of Science ®Google Scholar
• Shibutani S, Ravindernath A, Terashima I, et al. (2001). Mechanism of lower genotoxicity of toremifene compared with tamoxifen. Cancer Res 61:3925–3931.
   PubMed Web of Science ®Google Scholar
• Shimada T, Fujii-Kuriyama Y. (2004). Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 95:1–6.
   PubMed Web of Science ®Google Scholar
• Shao L-H, Liu S-P, Hou J-X, et al. (2012). Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: An experimental study. Cancer 118:2986–2996.
   PubMed Web of Science ®Google Scholar
• Shu Y-Z, Johnson BM, Yang TJ. (2008). Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. AAPS J 10:178–192.
   PubMed Web of Science ®Google Scholar
• Shon J, Abernethy DR. (2014). Application of systems pharmacology to explore mechanisms of hepatotoxicity. Clin Pharmacol Ther 96:536–537.
   PubMed Web of Science ®Google Scholar
• Sibbing D, Koch W, Massberg S, et al. (2011). No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting. Eur Heart J 32:1605–1613.
   PubMed Web of Science ®Google Scholar
• Sidorenko VS, Attaluri S, Zaitseva I, et al. (2014). Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis 35:1814–1822.
   PubMed Web of Science ®Google Scholar
• Silva MF, Aires CC, Luis PB, et al., (2008). Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review. J Inherit Metab Dis 31:205–216.
   PubMed Web of Science ®Google Scholar
• Sim E, Walters K, Boukouvala S. (2008). Arylamine N-acetyltransferases: From structure to function. Drug Metab Rev 40:479–510.
   PubMed Web of Science ®Google Scholar
• Slatter JG, Rashed MS, Pearson PG, et al. (1991). Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities. Chem Res Toxicol 4:157–161.
   PubMed Web of Science ®Google Scholar
• Smith PC, Benet LZ, McDonagh AF. (1990). Covalent binding of zomepirac glucuronide to proteins: Evidence for a Schiff base mechanism. Drug Metab Dispos 18:639–644.
   PubMed Web of Science ®Google Scholar
• Stangier J, Rathgen K, Gansser D, Roth W. (2007). The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol 64:292–303.
   PubMed Web of Science ®Google Scholar
• Stiborova M, Poljakova J, Ryslava H, et al. (2007). Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine. Int J Cancer 120:243–251.
   PubMed Web of Science ®Google Scholar
• Stiborova M, Rupertova M, Frei E. (2011). Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency. Biochim Biophys Acta 1814:175–185.
   PubMed Web of Science ®Google Scholar
• Surh YJ, Miller JA. (1994). Roles of electrophilic sulfuric acid ester metabolites in mutagenesis and carcinogenesis by some polynuclear aromatic hydrocarbons. Chem Biol Interact 92:351–362.
   PubMed Web of Science ®Google Scholar
• Tettey JN, Maggs JL, Rapeport WG, et al. (2001). Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo. Chem Res Toxicol 14:965–974.
   PubMed Web of Science ®Google Scholar
• Tang W, Lu AYH. (2010). Metabolic bioactivation and drug-related adverse effects: Current status and future directions from a pharmaceutical research perspective. Drug Metab Rev 42:225–249.
   PubMed Web of Science ®Google Scholar
• Thompson CD, Gulden PH, Macdonald TL. (1997). Identification of modified atropaldehyde mercapturic acids in rat and human urine after felbamate administration. Chem Res Toxicol 10:457–462.
   PubMed Web of Science ®Google Scholar
• Townsend DM, Hanigan MH. (2002). Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J Pharmacol Exp Ther 300:142–148.
   PubMed Web of Science ®Google Scholar
• Tornio A, Niemi M, Neuvonen M, et al. (2008). The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: Evidence for mechanism-based inhibition of CYP2C8 in vivo. Clin Pharmacol Ther 84:403–411.
   PubMed Web of Science ®Google Scholar
• Trevor AJ, Castagnoli N, Jr., Caldera P, et al. (1987). Bioactivation of MPTP: Reactive metabolites and possible biochemical sequelae. Life Sci 40:713–719.
   PubMed Web of Science ®Google Scholar
• Uetrecht J, Zahid N. (1988). N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite. Chem Res Toxicol 1:148–151.
   PubMed Web of Science ®Google Scholar
• Valstar DL, Schijf MA, Nijkamp FP, et al. (2004). Glutathione-conjugated toluene diisocyanate causes airway inflammation in sensitized mice. Arch Toxicol 78:533–539.
   PubMed Web of Science ®Google Scholar
• van Bladeren PJ. (2000). Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 129:61–76.
   PubMed Web of Science ®Google Scholar
• Van Ryn J, Stangier J, Haertter S, et al. (2010). Dabigatran etexilate – A novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103:1116–1127.
   PubMed Web of Science ®Google Scholar
• Vasiljeva O, Reinheckel T, Peters C, et al. (2007). Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 13:387–403.
   PubMed Web of Science ®Google Scholar
• Wallace JL. (2012). NSAID gastropathy and enteropathy: Distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol 165:67–74.
   PubMed Web of Science ®Google Scholar
• Walsh JS, Reese MJ, Thurmond LM. (2002). The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes. Chem-Biol Interact 142:135–154.
   PubMed Web of Science ®Google Scholar
• Walsh JS, Miwa GT. (2011). Bioactivation of drugs: Risk and drug design. Annu Rev Pharmacol Toxicol 51:145–167.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Tiefenthaler G, Georges G. (2014). Proteases as activators for cytotoxic prodrugs in antitumor therapy. Cancer Genom Proteom 11:67–80.
   PubMed Web of Science ®Google Scholar
• Wen B, Moore DJ. (2011). Bioactivation of glafenine by human liver microsomes and peroxidases: Identification of electrophilic iminoquinone species and GSH conjugates. Drug Metab Dispos 39:1511–1521.
   PubMed Web of Science ®Google Scholar
• Williams DP, Park BK. (2003). Idiosyncratic toxicity: The role of toxicophores and bioactivation. Drug Disco Today 8:1044–1050.
   PubMed Web of Science ®Google Scholar
• Yang K, Woodhead JL, Watkins PB, et al. (2014). Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicity. Clin Pharmacol Ther 96:589–598.
   PubMed Web of Science ®Google Scholar
• Yu J, Folmer JJ, Hoesch V, et al. (2011). Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: Formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening. Drug Metab Dispos 39:302–311.
   PubMed Web of Science ®Google Scholar
• Yuan JJ, Yang DC, Zhang JY, et al. (2002). Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human. Drug Metab Dispos 30:1013–1021.
   PubMed Web of Science ®Google Scholar
• Yueh MF, Nguyen N, Famourzadeh M, et al. (2001). The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Carcinogenesis 22:943–950.
   PubMed Web of Science ®Google Scholar
• Zhang D, Raghavan N, Chen SY, et al. (2008). Reductive isoxazole ring opening of the anticoagulant razaxaban is the major metabolic clearance pathway in rats and dogs. Drug Metab Dispos 36:303–315.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang L, Raghavan N, et al. (2007). Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Drug Metab Dispos 35:150–167.
   PubMed Web of Science ®Google Scholar
• Zhang F, Fan PW, Liu X, et al. (2000). Synthesis and reactivity of a potential carcinogenic metabolite of tamoxifen: 3,4-dihydroxytamoxifen-o-quinone. Chem Res Toxicol 13:53–62.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kolm RH, Mannervik B, Talalay P. (1995). Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem Biophys Res Commun 206:748–755.
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan E, Duan W, et al. (2005). Drug bioactivation covalent binding to target proteins and toxicity relevance. Drug Metab Rev 37:41–213.
   PubMed Web of Science ®Google Scholar
• Zhu H-J, Wang X, Gawronski BE, et al. (2013). Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation. J Pharmacol Exp Ther 344:665–672.
   PubMed Web of Science ®Google Scholar